
Bristol Cancer
@BristolCancer
Followers
493
Following
619
Media
47
Statuses
628
World-class research and excellence in cancer biology, population health and health-care based at the University of Bristol
Bristol, England
Joined July 2018
A new clinical trial is changing how we treat advanced melanoma. The DyNAMIc study uses blood tests to track tumour DNA in real time – helping doctors personalise treatment & reduce resistance. Speak with your GP if you're interested in taking part:
express.co.uk
EXCLUSIVE: Skin cancers can be among the most aggressive forms of the disease so using drugs to shrink them must be used with precision.
0
1
1
Share your #cancer #immunology research w/ #CSCancerImmunity2025 organizers Ignacio Melero @unav, Ira Mellman @parkerici, Fabiola Rivas, @ImmunityCP & Montse Rojo de la Vega @Cancer_Cell. Abstract deadline July 25 https://t.co/dsNT2THs5T
0
10
17
#InTheNews: At-home sampling kits to be offered to women and people with a cervix in England who aren't taking part in the life-saving cervical screening programme. The decision by @DHSCgovuk should help tackle barriers to screening and prevent more cases of cervical cancer 👇
2
14
24
🎓 Innovations in Experimental Cancer Medicine – free webinar 📅 28 May 2025 🕧 12:30 (BST) Learn about clinical trials, cutting-edge research & the MSc in Transformative Oncology at @OfficialUoM 🔗
0
1
0
Throughout the year we hold awareness stands in local areas so we can reach the people who need us most. We share important information about the symptoms of #BowelCancer and the bowel screening programme. We couldn't do this without our fantastic volunteers' support. Discover
0
1
11
📢 Event today! #DementiaActionWeek - Dementia research and me Join us for an informal drop-in day of fun activities, refreshments and a chance to hear about dementia research happening locally. 12pm, The Royal Hotel, #WestonSuperMare
https://t.co/XZe7WpiC8Q
5
2
5
Ahead of #InternationalClinicalTrialsDay tomorrow, meet Chloe, a Clinical Research Practitioner in the Early Phase Team at the Cambridge Cancer Trials Centre @CUH_NHS. Find out more in Chloe's spotlight ➡️ https://t.co/E7fu5znDT4
@CambridgeECMC #FocusOnCamCancer
0
2
6
🎭Theatre can bring research to life. But if the research is on a sensitive subject, it must be produced with care. 🔍Join us on 15 May for a webinar to launch a new how-to guide to co-developed theatre for disseminating research on sensitive subjects. https://t.co/G9ytrOVSPV
eventbrite.co.uk
Join us for this webinar to launch a new how-to guide to co-developed theatre as a format for disseminating research on sensitive subjects.
0
20
18
🚨 We're hiring! Join our Cancer Clinical Informatics team: ➡️ System Integration Specialist – https://t.co/AcnHOBY0QY (Closes 27 Apr) ➡️ Data Manager – https://t.co/kdpFYEUkNK (Closes 7 May)
0
2
2
Online Now: Cancer cell-derived arginine fuels polyamine biosynthesis in tumor-associated macrophages to promote immune evasion https://t.co/PqUz7aq0y5
4
44
123
This #BowelCancerAwarenessMonth we’ll be hosting four online awareness talks for you to attend. These talks are delivered by a trained volunteer, many of whom have a personal connection to #BowelCancer. This is your opportunity to learn more about the disease during our most
0
15
19
Announcing the speakers for Panel 1: Science & Healthcare Challenges at the CONNECTS-UK 3rd Open Forum Panel 1: Science & Healthcare Challenges Experts will discuss breakthroughs in cancer, cardiovascular health,computational biology, & infectious diseases in developing countries
1
2
2
NOW ONLINE! This review by @KiraKornienko1 et al. explores how chromatin variants shape tumor evolution and reveal novel treatment targets in #ProstateCancer. Also presented as a talk at the IJC Symposium on 14-Jan by @MatLupien 🔓OPEN ACCESS ➡️ https://t.co/mFuDxLnbVR
@uicc
1
2
4
🎉Exciting news - @CR_UK and partners have launched a £5.5m fund to research personalised treatments for bowel cancer. We're proud that our faculty member @christophertape and our Organoids facility are part of the international research team.
news.cancerresearchuk.org
The CRC-STARS team will learn more about how bowel cancer behaves so that it can potentially be treated in a more personalised way
1
4
16
📢 Join @CancerCoreEU for their next #CCELecture: Dissecting the function of copy number alterations in cancer with Francisco Barriga @@VHIOVHIO 📅 Thursday, April 10 ⏰ Time: 15:00 - 16:00 CEST Open to all! 🔗 Join Zoom Meeting: https://t.co/Eh0v3XrKkM Meeting ID: 886 4445 7350
0
1
1
From HeLa Cells to Digital #Health: Navigating the Promises and Pitfalls of Modern Clinical Research https://t.co/CnHevVJOkS
@matimbaswana @BrainTumourOrg @BristolCancer
nonprofitquarterly.org
As we advance into the digital health era, it will be crucial to...comprehend the specific challenges that people of color and other marginalized groups encounter in clinical research….By promoting...
0
2
3
🚨💬Last call for abstract submission! Don't miss it 👍
🚨 Abstract submissions for #PrevConf25 close this Sunday! Don't miss your chance to: ✅ Present your research to a global audience ✅ Collaborate with leading experts ✅ Help shape the future of cancer prevention 🔗 Submit now: https://t.co/rRbcHxnZw7
@theNCI |
0
0
1
Last call for research funding ⏰ Our 2025 grant call closes on 1 April! We’re looking for innovative ideas to improve early diagnosis of #BowelCancer. Apply now: https://t.co/9LB0PaBNrF
0
6
3
Calling all researchers! 📣 If you’ve been inspired by our latest research projects, we’re currently open for new applications for early diagnosis project grants. Find out more here: https://t.co/9LB0PaBNrF
bowelcanceruk.org.uk
Early diagnosis Project Grants funding call is now closed.
We’re excited to announce we’re awarding three new research grants! 📣 These projects are focusing on improving early diagnosis of #BowelCancer. The focus on early diagnosis was chosen because the disease is treatable if caught early.
0
3
8
Applications are now open for our RDICA Funding Scheme, which supports collaborative research development between @BristolUni and international researchers. Deadline 1st May 2025. Find out more:
0
1
2